Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.

Rotschafer, Sarah E; Trujillo, Michael S; Dansie, Lorraine E; Ethell, Iryna M; Razak, Khaleel A

Rotschafer, Sarah E; Trujillo, Michael S; Dansie, Lorraine E; Ethell, Iryna M; Razak, Khaleel A.

Affiliation

Rotschafer SE; Neuroscience Graduate Program, University of California, Riverside, CA-92521, USA.

Brain Res ; 1439: 7-14, 2012 Feb 23.

Article in En | MEDLINE | ID: mdl-22265702

Subject(s)

Fragile X Syndrome/drug therapy; Fragile X Syndrome/psychology; Minocycline/pharmacology; Sexual Behavior, Animal/drug effects; Vocalization, Animal/drug effects; Animals; Disease Models, Animal; Female; Fragile X Mental Retardation Protein/genetics; Fragile X Syndrome/physiopathology; Male; Mice; Mice, Knockout

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Sexual Behavior, Animal / Vocalization, Animal / Fragile X Syndrome / Minocycline Type of study: Prognostic_studies Limits: Animals Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google